Frequently Used Allopathic and Traditional Medicine for COVID-19 Treatment and Feasibility of Their Integration  

作　　者：Aditya Upadhayay Gopal Patel Dharm Pal Awanish Kumar 

机构地区：[1]Department of Biotechnology,National Institute of Technology,Raipur,CG(492010),India [2]Laboratory of Medicinal Plant Biotechnology,College of Pharmacy,Zhejiang Chinese Medical University,Hangzhou(310053),China [3]Department of Chemical Engineering,National Institute of Technology,Raipur,CG(492010),India

出　　处：《Chinese Journal of Integrative Medicine》2022年第11期1040-1047,共8页中国结合医学杂志（英文版）

摘　　要：To date,no satisfactory treatment for COVID-19 is available.This review reported few recent updates regarding the drugs(allopathy/traditional medicines)used for the treatment of COVID-19 concerning clinical studies.Content of the article spotlight the contribution of allopathic and Ayurvedic drugs to the scientific basis for utilization as a potential therapy against COVID-19 infection and provide new insights on the integration of allopathy and traditional medicine.It advocated the combination of these two systems of treatment will ascertain their integrations,and there would be a good possibility and scope for developing a model of integration in the management of COVID-19.Provided discussion may help researchers,physicians,and healthcare policymakers to encourage for effective and integrated use of allopathic and Ayurvedic medicines to control the COVID-19 pandemic more effectively.

关 键 词：COVID-19 allopathy traditional medicine INTEGRATION promising therapy 

分 类 号：R563.1[医药卫生—呼吸系统]